NYXH · NYXOAH S A

Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

Rue Edouard Belin 12, Mont-Saint-Guibert, 1435, Belgium
Medical Devices
Healthcare

Market Cap

129.3M

52 Wk Range

$1.26 - $6.88

Previous Close

$1.27

Open

$1.34

Volume

264,064

Day Range

$1.34 - $1.47

Enterprise Value

86.74M

Cash

97.79M

Avg Qtr Burn

-16.57M

Insider Ownership

33.19%

Institutional Own.

29.90%

Qtr Updated

Jun 30th 2026